Korro to Present at the 2026 Jefferies Global Healthcare Conference May 27, 2026 07:00AM
Korro Bio selects KRRO-111 for alpha-1 antitrypsin deficiency treatment May 19, 2026 07:00AM
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD) May 19, 2026 07:00AM
Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update May 7, 2026 07:00AM
Korro to Participate in Upcoming Investor Conferences May 5, 2026 04:05PM


Apr 16, 2026 07:30AM Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences
Apr 16, 2026 07:30AM Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences
Mar 12, 2026 04:05PM Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 25, 2026 04:05PM Korro to Present at the TD Cowen 46th Annual Health Care Conference
Jan 20, 2026 08:00AM Korro to Host Virtual Analyst Day on January 27, 2026
Jan 8, 2026 08:00AM Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference
Nov 12, 2025 04:52PM Korro Bio reports mixed results from KRRO-110 trial, cuts workforce by third
Nov 12, 2025 04:05PM Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs
Sep 2, 2025 04:30PM Korro to Participate in Upcoming Investor and Scientific Conferences
Aug 12, 2025 07:00AM Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates
Jul 21, 2025 08:04AM Korro Bio receives European orphan drug designation for KRRO-110
Jul 21, 2025 08:00AM Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110
May 14, 2025 04:05PM Korro to Participate in Upcoming Investor Conferences
May 7, 2025 04:30PM Korro Reports First Quarter 2025 Financial Results and Provides Business Updates
Apr 1, 2025 07:32AM Korro Bio (KRRO) Appoints Loïc Vincent as Chief Scientific Officer
Apr 1, 2025 07:30AM Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer
Mar 18, 2025 07:00AM Korro Reports Full Year 2024 Financial Results and Provides Business Updates
Mar 14, 2025 08:01AM Korro Bio (KRRO): KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
Mar 14, 2025 08:00AM KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency